跳至主要内容
临床试验/NCT04883931
NCT04883931已完成不适用

The Effect of Using Breast Milk as a Topical Ophthalmic Drop on Retinopathy of Prematurity. Randomized Placebo-controlled Trial.

Baskent University1 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2021年5月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
101
试验地点
1
主要终点
Retinopathy of Prematurity

研究概览

简要总结

The aim of this study is to investigate the effect of using breast milk as eye drops on ROP (Retinopathy of prematurity) disease observed in less then 32 weeks gestational age preterm babies.

详细描述

Study Design: Prospective randomized placebo controlled trial Setting/Participants: Premature babies who are at high risk for retinopathy of prematurity (ROP) during their stay in the neonatal intensive care unit (NICU). The study will be carried out at Baskent University and it is planned that 70 participants will be included in the study.

Study Interventions and Measures: After the randomization of the patients, 0.5 ml breast milk of the babies' own mothers will drop on the eye to the intervention group twice a day. IN the control group, %0.9 normal saline will drop as same amount. Primary outcome is any stage of ROP, secondary outcome is severe ROP (laser requiring ROP).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Participant and Ophthalmologist who is the responsible the follow -up the ROP stages will be blind in the study. The neonatologist who is responsible for the care and follow-up of the patients will not be blind.

入排标准

年龄范围
22 Weeks 至 32 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Infants born between 22 and 32 gestational age weeks or under 1500 gr birth weight.

排除标准

  • Infant death before first examination for ROP
  • parents who want to leave from the study
  • Contraindications for breast milk use (Active HIV infection, Active tuberculosis, CMV infection)
  • Inborn error of metabolism like galactosemia.
  • Congenital eye development disorders like agenesis, or situations that do not allow retina examination.
  • other lethal congenital molformations
  • congenital infections that affect the retina like TORCH infections.

研究组 & 干预措施

Intervention group

Experimental

With in 48-72 hour after birth, infants will receive 0.5 ml breast milk for own mother as a eye drop twice in a day until the discharge or need for laser coagulation. Fresh milk was used as eye drop ( not exceed 6 hours after milking).

干预措施: Breast milk (Biological)

Placebo group

Placebo Comparator

With in 48-72 hour after birth, infants will receive 0.5 ml 0.9% normal saline as a eye drop twice in a day until the discharge or need for laser coagulation.

干预措施: Normal Saline (Drug)

结局指标

主要结局

Retinopathy of Prematurity

时间窗: by 55 weeks post menstrual age

Number of participants with any stage of ROP

次要结局

  • Retinopathy of Prematurity(by 55 weeks post menstrual age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Musa Silahli

Principal Investigator

Baskent University

研究点 (1)

Loading locations...

相似试验